Loading company details...
Beta
Latest Form 4 (Sep 30, 2026): John L. Higgins (Director): Exercise/Conversion of 15,940 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | John L. Higgins | Exercise/Conversion | 15,940 | n/a |
| Sep 24, 2026 | Robert Baumgartner V | Exercise/Conversion | 15,940 | n/a |
| Aug 19, 2026 | Shane Bohnen, SVP - General Counsel | Grant/Award | 11,344 | n/a |
| Aug 19, 2026 | Kim Kelderman, Chief Executive Officer | Grant/Award | 57,590 | n/a |
| Aug 19, 2026 | James Hippel, CFO | Grant/Award | 22,438 | n/a |
| Aug 19, 2026 | Amy E. Herr | Grant/Award | 1,381 | n/a |
| Aug 19, 2026 | William Geist, PRESIDENT, PROTEIN SCIENCES | Grant/Award | 14,762 | n/a |
| Aug 19, 2026 | Steven C. Crouse, President - Diag & Spatial Bi | Grant/Award | 8,702 | n/a |
| Aug 18, 2026 | Kim Kelderman, Chief Executive Officer | Exercise/Conversion | 21,470 | n/a |
| Aug 18, 2026 | James Hippel, CFO | Exercise/Conversion | 9,779 | n/a |